Veradigm | MDRX - Assets


Veradigm reported $1.5B in Assets for its fiscal quarter ending in December of 2022.





Assets Change Date
Alcidion AUD 118.08M 2.46M Dec/2025
Ambu A/S DKK 7.61B 25M Mar/2026
Amplifon EUR 3.6B 328.33M Jun/2026
Cardinal Health USD 56.69B 1.39B Mar/2026
Centene USD 83.01B 1.84B Jun/2026
Charles River Laboratories USD 7.73B 594.89M Mar/2026
Cigna USD 157.08B 3.82B Jun/2026
Coloplast 48.8B 429M Dec/2025
Convatec Group USD 3.52B 109.3M Dec/2024
CVS Health USD 252.97B 564M Mar/2026
Diasorin EUR 2.87B 257.21M Jun/2025
Elevance Health USD 126.44B 611M Jun/2026
General Electric Aerospace USD 127.67B 773M Jun/2026
Gulf Medical Proj AED 1.55B 85.18M Dec/2025
Humana USD 57.2B 1.92B Jun/2026
IQVIA Holdings USD 29.88B 206M Jun/2026
Laboratory Of America USD 18.53B 554.8M Jun/2026
Maximus USD 4.24B 30.87M Mar/2026
McKesson USD 82.32B 1.87B Mar/2026
Med Life RON 3.34B 76.39M Mar/2026
Molina Healthcare USD 16B 388M Jun/2026
Omnicell USD 2B 5.25M Jun/2026
Oriola-kd EUR 796.5M 149.6M Mar/2026
Owens Minor USD 2.42B 35.78M Mar/2026
Quest Diagnostics USD 16.94B 266M Jun/2026
Rede D'or Sao Luiz BRL 109.77B 3.22B Mar/2026
Siemens Healthineers EUR 45.74B 931M Jun/2026
Sonova Holding CHF 5.92B 468.2M Jun/2025
Supermax Corporation Bhd MYR 4.13B 37.88M Mar/2026
UnitedHealth USD 309.73B 2.92B Jun/2026
Veeva Systems USD 9.13B 150.22M Mar/2026
Veradigm USD 1.5B 185.94M Dec/2022
Xerox USD 9.9B 79M Mar/2026